Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?-Reference-Cited by-同舟云学术

Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?

Published:2015-06-09 Issue:5 Volume:37 Page:723-728
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int. Jnl. Lab. Hem.

Author:

Kelani R.¹,Monem F.¹²

Affiliation:

1. Department of Biochemistry and Microbiology; Faculty of Pharmacy; Damascus University; Damascus Syria

2. Clinical Laboratories Department; AL-Assad Hospital; Damascus University; Damascus Syria

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Reference19 articles.

1. Chronic myeloid leukemia in 2007;Sessions;Am J Health Syst Pharm,2007

2. Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia;Wang;Br J Haematol,2002

3. Advances in the treatment of chronic myeloid leukemia;Eiring;BMC Med,2011

4. Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay;Dekking;Best Pract Res Clin Haematol,2010

5. An accurate and rapid flow cytometric diagnosis of BCR ABL fusion protein an alternative way to detect the different phases of chronic myeloid leukemia;Dasgupta;Int J Adv Sci Tech Res,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to molecular monitoring in CML (and other diseases);Blood;2019-09-18

2. Molecular monitoring of chronic myeloid leukemia: present and future;Expert Review of Molecular Diagnostics;2016-09-06

3. New Methodologies in the Molecular Monitoring of CML;Current Hematologic Malignancy Reports;2016-03-05